Fin|Tech|Bio at Canary Wharf: Synthetic vs Real World Data (RWD

Following on from our hugely successful sold-out event in March, Canary Wharf Life Sciences and Level39 are excited to announce the second edition of Fin|Tech|Bio at Canary Wharf, taking place on Tuesday, 14th October, from 5:30pm - 8:00pm, at Level39, Canary Wharf. Expect thought-provoking discussions, meaningful connections, and an opportunity to engage with the growing Canary Wharf life sciences and tech ecosystem.

Fin|Tech|Bio is a collaborative event series exploring the convergence of biotech/techbio, finance and technology.

Synthetic data is rapidly transforming how sensitive and complex data is accessed, analysed and shared across sectors. In this second edition, our experts will discuss the growing role of synthetic data in life sciences and finance applications - two industries where data privacy, regulatory compliance and model robustness are paramount – and delve into the pros and cons of Real World Data vs Synthetic Data uses.

Speakers include:

  • James Duboff, Strategic Partnerships Director, Genomics England 
  • Dr Tim Williams, Head of Interventional Research, CPRD MHRA
  • Sam Genway, Scientific Director, Machine Learning and AI, LifeArc
  • Prof. Andy Pardoe, Founder/Director, InformedAI/Venture Flow/Investor
  • Jean-Philippe Schepens, AxonJay.ai
  • Shilina Roman, C4XDiscovery

This event is ideal for:

Founders, innovators and startups in healthtech, techbio, fintech, and AI/tech

Investors exploring the frontier of data innovation

Regulators, data scientists and research professionals